ASX:OVN

Oventus Medical (OVN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
289,932 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
OVN stock logo

About Oventus Medical Stock (ASX:OVN)

Oventus Medical Limited, a medical device company, engages in the development and commercialization of oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a 3D-printed nylon oral appliance for OSA patients; and ExVent, a valve accessory that fits into the open airway of the O2Vent Optima device. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.

OVN Stock News Headlines

How to Get Help Paying Medical Bills
Travel Medical Insurance Plans for Emergency Coverage
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
Oventus Medical Ltd (OVN)
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
Oventus Medical Ltd
Oventus Medical Limited (OVN.AX)
Oventus Medical Limited's (ASX:OVN) Profit Outlook
See More Headlines
Receive OVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oventus Medical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-10,290,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.09 million
Book Value
A$0.03 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.66
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. John Cox
    CEO, Pres & COO
  • Mr. James Hunter
    Acting Chief Financial Officer
  • Dr. Stephen Denaro AGIA
    BCom, CA, GradDipApp CG, MAICD, Company Sec.

This page (ASX:OVN) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners